Lv11
50 积分 2025-07-16 加入
IL-6 Blockade in Cytokine Storm Syndromes
1小时前
待确认
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
6天前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
1个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
1个月前
已完结
Atopic dermatitis
3个月前
已完结
Immunoglobulin E as a Biomarker in Asthma
3个月前
已完结
Irinotecan Resistance is Accompanied by Upregulation of EGFR and Src Signaling in Human Cancer Models
4个月前
已完结
Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
4个月前
已完结
Exploring the role of ITGB6: fibrosis, cancer, and other diseases
5个月前
已完结
皖公网安备34019202002308
